← Leaderboards
Eric Kaldjian
Rarecyte, Inc.
$1,819,493
Attributed
$2,816,279
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–21$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,816,279 · 3
By mechanism
R44$1,993,572 · 1
R43$598,867 · 1
R41$223,840 · 1
Top collaborators
- Steven Reese2 shared
Most similar at Rarecyte, Inc.
Same institution · by research overlap
- Steven Reese$996,786
- Tad George$658,336
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesAntigensLaboratoriesBaseSamplingClinical ResearchSignal TransductionReagentInstrumentTechnologyEngineeringValidationResponseDiagnosticLegal PatentResearch PersonnelImaging ModalityImageFormalinImage ProcessingImmuneDiagnostic ProcedureCancer TypeBlood
Grant awards (5)
Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging$847,774
R44 · FY2021 · CA · contact PI
Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging$1,145,798
R44 · FY2020 · CA · contact PI
Highly Multiplexed Analysis of Solid Tumors and Liquid Tissues by Cyclic Immunofluorescence$223,840
R41 · FY2018 · CA · contact PI
Direct visualization assay for detection of B. burgdorferi in early Lyme Disease$299,366
R43 · FY2015 · AI · contact PI
Direct visualization assay for detection of B. burgdorferi in early Lyme Disease$299,501
R43 · FY2014 · AI · contact PI